Ido Marom - 18 Mar 2026 Form 3 Insider Report for Brainsway Ltd. (BWAY)

Role
Chief Financial Officer
Signature
/s/ Ido Marom
Issuer symbol
BWAY
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 16:04:48 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Marom Ido Chief Financial Officer 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL /s/ Ido Marom 18 Mar 2026 0002111633

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BWAY Ordinary Shares 51,250 18 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BWAY Stock Options (right to buy) 18 Mar 2026 Ordinary Shares 46,875 Direct F1, F3, F4
holding BWAY Stock Options (right to buy) 18 Mar 2026 Ordinary Shares 17,500 Direct F1, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This figure includes unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 8,750 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029, and (c) RSUs to receive 32,500 ordinary shares with 8,125 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
F3 Stock options were granted on August 8, 2023, with the remaining options to purchase 46,875 ordinary shares vesting in equal quarterly installments until May 18, 2027.
F4 The exercise price is NIS 4.28 per share.
F5 Stock options were granted on March 5, 2024, with the remaining options to purchase 17,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
F6 The exercise price is NIS 11.17 per share.